ESR1 and neoplasm: Given that a large amount of ER-positive patients receive unnecessary chemotherapy [28], predictive biomarkers such as these are extremely useful in tailoring treatment based on molecular aspects of a patient’s tumor in addition to clinical and pathologic characteristics.